These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33474856)

  • 21. Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous rrticaria - A real-life experience.
    Maoz-Segal R; Levy T; Haj-Yahia S; Offengenden I; Iancovich-Kidon M; Agmon-Levin N
    World Allergy Organ J; 2020 Aug; 13(8):100448. PubMed ID: 32774663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.
    Casale TB; Gimenez-Arnau AM; Bernstein JA; Holden M; Zuberbier T; Maurer M
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2573-2588. PubMed ID: 37776480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?
    Altrichter S; Peter HJ; Pisarevskaja D; Metz M; Martus P; Maurer M
    PLoS One; 2011 Apr; 6(4):e14794. PubMed ID: 21532759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower IgA Levels in Chronic Spontaneous Urticaria Are Associated With Lower IgE Levels and Autoimmunity.
    Sauer M; Scheffel J; Frischbutter S; Kolkhir P; Xiang YK; Siebenhaar F; Altrichter S; Maurer M; Metz M; Krause K
    Front Immunol; 2021; 12():657211. PubMed ID: 34012441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab Treatment.
    Can Bostan O; Damadoglu E; Sarac BE; Kilic B; Sahiner UM; Karaaslan C; Karakaya G; Kalyoncu AF
    Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria.
    Sauer M; Scheffel J; Frischbutter S; Mahnke N; Maurer M; Burmeister T; Krause K; Metz M
    Front Immunol; 2022; 13():902652. PubMed ID: 35928809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omalizumab in chronic spontaneous and inducible urticaria: a 9 year retrospective study in Portugal.
    Marcelino J; Costa AC; Mendes A; Alonso E; Cabral Duarte F; Pedro E; Pereira-Barbosa M
    Eur Ann Allergy Clin Immunol; 2018 Jul; 50(4):169-176. PubMed ID: 29479938
    [No Abstract]   [Full Text] [Related]  

  • 28. The CD63 basophil activation test as a diagnostic tool for assessing autoimmunity in patients with chronic spontaneous urticaria.
    HOssein Zadeh Attar M; Merk HF; Kotliar K; Wurpts G; Röseler S; Moll-Slodowy S; Plange J; Baron JM; Balakirski G
    Eur J Dermatol; 2019 Dec; 29(6):614-618. PubMed ID: 31903951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
    Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
    Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis.
    Keller L; Perera EK; Bindon B; Khatiwada A; Stitt JM; Dreskin SC
    Allergy Asthma Proc; 2024 Mar; 45(2):97-99. PubMed ID: 38449010
    [No Abstract]   [Full Text] [Related]  

  • 31. Biomarkers of treatment efficacy in patients with chronic spontaneous urticaria.
    Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F; González-Aveledo L
    Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):5-9. PubMed ID: 29350016
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE.
    Kolkhir P; Kovalkova E; Chernov A; Danilycheva I; Krause K; Sauer M; Shulzhenko A; Fomina D; Maurer M
    J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4138-4146.e8. PubMed ID: 34363991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
    Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
    Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.
    Giménez-Arnau AM
    Expert Opin Biol Ther; 2017 Mar; 17(3):375-385. PubMed ID: 28125304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omalizumab may not inhibit mast cell and basophil activation in vitro.
    Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
    Metz M; Ohanyan T; Church MK; Maurer M
    J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In chronic spontaneous urticaria, IgE and C-reactive protein are linked to distinct microRNAs and interleukin-31.
    Karstarli Bakay OS; Demir B; Cicek D; Erol D; Aşçı Toraman Z; Gural Y; Maurer M
    Clin Transl Allergy; 2023 Aug; 13(8):e12290. PubMed ID: 37632245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria.
    Keskinkaya Z; Kaya Ö; Işık Mermutlu S; Öğretmen Z
    Int Arch Allergy Immunol; 2024 Apr; ():1-8. PubMed ID: 38626739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.
    Metz M; Vadasz Z; Kocatürk E; Giménez-Arnau AM
    Clin Rev Allergy Immunol; 2020 Aug; 59(1):38-45. PubMed ID: 32418171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of omalizumab treatment on IgE and other immunoglobulin levels in patients with chronic spontaneous urticaria and its association with treatment response.
    Çildağ S; Şentürk T
    Postepy Dermatol Alergol; 2018 Oct; 35(5):516-519. PubMed ID: 30429712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.